Efficacy and safety of finerenone in IgA nephropathy: an observational multicentre study
Clin Kidney J. 2025 Apr 28;18(5):sfaf125. doi: 10.1093/ckj/sfaf125. eCollection 2025 May. ABSTRACT BACKGROUND: Finerenone, a non-steroidal mineralocorticoid receptor antagonist, reduces renal risks in type 2 …